Institutional Ownership Halozyme Therapeutics, Inc. (HALO)
This table provides information about the institutional ownership of Halozyme Therapeutics, Inc. (HALO). We have compiled data on the 664 institutions that hold shares in the stock, with a total of 128 Million shares, which have been reported (via 13F filing form) to have a value of $8.95 Billion.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Northern Trust Corp
Chicago, IL |
Nov 14, 2025 Q3 2025 |
1,167,141
shares
|
$81.7 Million
0.01% of portfolio
|
Q3 2025
Added 9.45%
|
|
|
Royal London Asset Management LTD
United Kingdom, X0 |
Nov 13, 2025 Q3 2025 |
1,143,257
shares
|
$80.1 Million
0.19% of portfolio
|
Q3 2025
Added 3.75%
|
|
|
Los Angeles Capital Management LLC
|
Oct 20, 2025 Q3 2025 |
1,081,074
shares
|
$75.7 Million
0.28% of portfolio
|
Q3 2025
Added 11.03%
|
|
|
Franklin Resources Inc
San Mateo, CA |
Nov 13, 2025 Q3 2025 |
1,076,335
shares
|
$75.4 Million
0.02% of portfolio
|
Q3 2025
Added 23.2%
|
|
|
Jane Street Group, LLC
New York, NY |
Nov 13, 2025 Q3 2025 |
1,075,368
shares
|
$75.3 Million
0.01% of portfolio
|
Q3 2025
Added 11.21%
|
|
|
Voloridge Investment Management, LLC
Jupiter, FL |
Nov 14, 2025 Q3 2025 |
1,057,902
shares
|
$74.1 Million
0.28% of portfolio
|
Q3 2025
New holding
|
|
|
Td Asset Management Inc
|
Nov 10, 2025 Q3 2025 |
1,035,170
shares
|
$72.5 Million
0.07% of portfolio
|
Q3 2025
Reduced 5.1%
|
|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
Nov 13, 2025 Q3 2025 |
1,000,209
shares
|
$70 Million
0.1% of portfolio
|
Q3 2025
Added 195.39%
|
|
|
Aqr Capital Management LLC
Greenwich, CT |
Nov 14, 2025 Q3 2025 |
968,511
shares
|
$67.8 Million
0.05% of portfolio
|
Q3 2025
Added 155.68%
|
|
|
Janus Henderson Group PLC
London, X0 |
Nov 14, 2025 Q3 2025 |
958,029
shares
|
$67.1 Million
0.03% of portfolio
|
Q3 2025
Added 5.23%
|
|
|
Royal Bank Of Canada
Toronto, A6 |
Nov 14, 2025 Q3 2025 |
950,846
shares
|
$66.6 Million
0.01% of portfolio
|
Q2 2025
Reduced 2.02%
|
|
|
Arrow Mark Colorado Holdings LLC
Denver, CO |
Nov 14, 2025 Q3 2025 |
924,875
shares
|
$64.8 Million
1.45% of portfolio
|
Q3 2025
Added 6.69%
|
|
|
Jacobs Levy Equity Management, Inc
Florham Park, NJ |
Nov 17, 2025 Q3 2025 |
898,192
shares
|
$62.9 Million
0.28% of portfolio
|
Q3 2025
Reduced 10.42%
|
|
|
Boston Trust Walden Corp
|
Oct 17, 2025 Q3 2025 |
833,893
shares
|
$58.4 Million
0.46% of portfolio
|
Q3 2025
Reduced 1.34%
|
|
|
Capital World Investors
Los Angeles, CA |
Nov 13, 2025 Q3 2025 |
831,656
shares
|
$58.2 Million
0.01% of portfolio
|
Q3 2025
Added 6.35%
|
|
|
Price T Rowe Associates Inc
Baltimore, MD |
Nov 14, 2025 Q3 2025 |
825,425
shares
|
$57.8 Million
0.01% of portfolio
|
Q3 2025
Reduced 20.03%
|
|
|
Jupiter Asset Management LTD
|
Nov 10, 2025 Q3 2025 |
800,583
shares
|
$56.1 Million
0.52% of portfolio
|
Q3 2025
Added 19.38%
|
|
|
Caisse De Depot Et Placement Du Quebec
Montreal, A8 |
Nov 14, 2025 Q3 2025 |
776,635
shares
|
$54.4 Million
0.11% of portfolio
|
Q3 2025
Reduced 42.09%
|
|
|
First Trust Advisors LP
Wheaton, IL |
Nov 12, 2025 Q3 2025 |
776,411
shares
|
$54.4 Million
0.04% of portfolio
|
Q3 2025
Added 1.37%
|
|
|
Jpmorgan Chase & CO
New York, NY |
Nov 26, 2025 Q3 2025 |
767,840
shares
|
$53.8 Million
0.0% of portfolio
|
Q3 2025
Reduced 68.97%
|
|
|
Goldman Sachs Group Inc
New York, NY |
Nov 14, 2025 Q3 2025 |
684,523
shares
|
$47.9 Million
0.01% of portfolio
|
Q3 2025
Reduced 49.95%
|
|
|
Nuveen, LLC
Charlotte, NC |
Nov 12, 2025 Q3 2025 |
653,121
shares
|
$45.7 Million
0.01% of portfolio
|
Q3 2025
Added 35.95%
|
|
|
Victory Capital Management Inc
|
Nov 12, 2025 Q3 2025 |
623,029
shares
|
$43.6 Million
0.03% of portfolio
|
Q3 2025
Reduced 6.94%
|
|
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
Nov 14, 2025 Q3 2025 |
610,000
shares
|
$42.7 Million
0.1% of portfolio
|
Q3 2025
Added 113.74%
|
|
|
Qube Research & Technologies LTD
London, X0 |
Nov 14, 2025 Q3 2025 |
601,276
shares
|
$42.1 Million
0.05% of portfolio
|
Q3 2025
Reduced 39.02%
|
|